{"count": 125, "results": [{"_id": "33753958", "pmid": 33753958, "pmcid": "PMC7966930", "title": "Cardioprotective Effects of Mebudipine in a Rat Model of Doxorubicin-Induced Heart Failure", "journal": "Iran J Med Sci", "authors": ["Aali E", "Ghaznavi H", "Soltanpour MS", "Mahmoudian M", "Shafiei M"], "date": "2021-03-01T00:00:00Z", "doi": "10.30476/ijms.2019.82057.0", "meta_date_publication": "2021 Mar", "meta_volume": "46", "meta_issue": "2", "meta_pages": "136-143", "score": 50264.27, "text_hl": "The administration of CCBs, except for @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, should be avoided in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@congestive HF@@@. ", "citations": {"NLM": "Aali E, Ghaznavi H, Soltanpour MS, Mahmoudian M, Shafiei M. Cardioprotective Effects of Mebudipine in a Rat Model of Doxorubicin-Induced Heart Failure Iran J Med Sci. 2021 Mar;46(2):136-143. PMID: 33753958", "BibTeX": "@article{33753958, title={Cardioprotective Effects of Mebudipine in a Rat Model of Doxorubicin-Induced Heart Failure}, author={Aali E and Ghaznavi H and Soltanpour MS and Mahmoudian M and Shafiei M}, journal={Iran J Med Sci}, volume={46}, number={2}, pages={136-143}}"}}, {"_id": "40770295", "pmid": 40770295, "title": "Unfavorable influence of amlodipine combined with metoprolol on the short-term prognosis in hypertensive heart failure patients.", "journal": "BMC Cardiovasc Disord", "authors": ["Liu ZQ", "Hao ZW", "Chen HS", "Yu FH", "Pang GY", "Zhou WQ", "Tang JN", "Li CJ"], "date": "2025-08-06T00:00:00Z", "doi": "10.1186/s12872-025-05077-w", "meta_date_publication": "2025 Aug 6", "meta_volume": "25", "meta_issue": "1", "meta_pages": "582", "score": 50257.926, "text_hl": "Unfavorable influence of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ combined with @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ on the short-term prognosis in @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@hypertensive heart failure@@@ @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Liu ZQ, Hao ZW, Chen HS, Yu FH, Pang GY, Zhou WQ, Tang JN, Li CJ. Unfavorable influence of amlodipine combined with metoprolol on the short-term prognosis in hypertensive heart failure patients. BMC Cardiovasc Disord. 2025 Aug 6;25(1):582. PMID: 40770295", "BibTeX": "@article{40770295, title={Unfavorable influence of amlodipine combined with metoprolol on the short-term prognosis in hypertensive heart failure patients.}, author={Liu ZQ and Hao ZW and Chen HS and Yu FH and Pang GY and Zhou WQ and Tang JN and Li CJ}, journal={BMC Cardiovasc Disord}, volume={25}, number={1}, pages={582}}"}}, {"_id": "38045912", "pmid": 38045912, "pmcid": "PMC10690815", "title": "Impact of amlodipine on clinical outcomes for heart failure in patients with dilated cardiomyopathy: a Korean nationwide cohort study", "journal": "Front Cardiovasc Med", "authors": ["Bae S", "Kim WK", "You SC", "Kim M", "Jung IH"], "date": "2023-11-17T00:00:00Z", "doi": "10.3389/fcvm.2023.1305824", "meta_date_publication": "2023", "meta_volume": "10", "meta_issue": "", "meta_pages": "1305824", "score": 50257.88, "text_hl": "Impact of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on clinical outcomes for @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@heart failure@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Cardiomyopathy_Dilated @DISEASE_MESH:D002311 @@@dilated cardiomyopathy@@@: a Korean nationwide cohort study", "citations": {"NLM": "Bae S, Kim WK, You SC, Kim M, Jung IH. Impact of amlodipine on clinical outcomes for heart failure in patients with dilated cardiomyopathy: a Korean nationwide cohort study Front Cardiovasc Med. 2023;10():1305824. PMID: 38045912", "BibTeX": "@article{38045912, title={Impact of amlodipine on clinical outcomes for heart failure in patients with dilated cardiomyopathy: a Korean nationwide cohort study}, author={Bae S and Kim WK and You SC and Kim M and Jung IH}, journal={Front Cardiovasc Med}, volume={10}, pages={1305824}}"}}, {"_id": "37587697", "pmid": 37587697, "title": "Improvement in hemodynamics of amlodipine besylate combined with metoprolol in patients with hypertension complicated by heart failure.", "journal": "Pak J Pharm Sci", "authors": ["Chen C", "Zhang W", "Jiao D", "Shen J", "Zhu G", "Zhang X"], "date": "2023-05-01T00:00:00Z", "meta_date_publication": "2023 May", "meta_volume": "36", "meta_issue": "3(Special)", "meta_pages": "909-914", "score": 50257.773, "text_hl": "Improvement in hemodynamics of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine besylate@@@ combined with @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ in patients with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ complicated by @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@heart failure@@@.", "citations": {"NLM": "Chen C, Zhang W, Jiao D, Shen J, Zhu G, Zhang X. Improvement in hemodynamics of amlodipine besylate combined with metoprolol in patients with hypertension complicated by heart failure. Pak J Pharm Sci. 2023 May;36(3(Special)):909-914. PMID: 37587697", "BibTeX": "@article{37587697, title={Improvement in hemodynamics of amlodipine besylate combined with metoprolol in patients with hypertension complicated by heart failure.}, author={Chen C and Zhang W and Jiao D and Shen J and Zhu G and Zhang X}, journal={Pak J Pharm Sci}, volume={36}, number={3(Special)}, pages={909-914}}"}}, {"_id": "38530625", "pmid": 38530625, "title": "Acute High-Output Heart Failure with Pulmonary Hypertension and Severe Liver Injury Caused by Amlodipine Poisoning: A Case Report.", "journal": "Cardiovasc Toxicol", "authors": ["Wang C", "Zhu Q", "Tan D", "Walline J", "Wang Y"], "date": "2024-03-26T00:00:00Z", "doi": "10.1007/s12012-024-09849-2", "meta_date_publication": "2024 Mar 26", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50252.37, "text_hl": "...@<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@Acute high-output heart failure@@@ (@<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@HOHF@@@) with @DISEASE_Hypertension_Pulmonary @DISEASE_MESH:D006976 @@@pulmonary hypertension@@@ and @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver injury@@@ caused by @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ @DISEASE_Poisoning @DISEASE_MESH:D011041 @@@poisoning@@@ is very rare. ", "citations": {"NLM": "Wang C, Zhu Q, Tan D, Walline J, Wang Y. Acute High-Output Heart Failure with Pulmonary Hypertension and Severe Liver Injury Caused by Amlodipine Poisoning: A Case Report. Cardiovasc Toxicol. 2024 Mar 26;():. PMID: 38530625", "BibTeX": "@article{38530625, title={Acute High-Output Heart Failure with Pulmonary Hypertension and Severe Liver Injury Caused by Amlodipine Poisoning: A Case Report.}, author={Wang C and Zhu Q and Tan D and Walline J and Wang Y}, journal={Cardiovasc Toxicol}}"}}, {"_id": "33041135", "pmid": 33041135, "title": "Efficacy of methylene blue in a murine model of amlodipine overdose.", "journal": "Am J Emerg Med", "authors": ["de Castro Brás LE", "Baccanale CL", "Eccleston L", "Sloan T", "St Antoine JC", "Verzwyvelt SM", "Pittman P", "O'Rourke D", "Meggs WJ"], "date": "2021-07-01T00:00:00Z", "doi": "10.1016/j.ajem.2020.08.077", "meta_date_publication": "2021 Jul", "meta_volume": "45", "meta_issue": "", "meta_pages": "284-289", "score": 50251.707, "text_hl": "DISCUSSION: The @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ dose induced @DISEASE_Cardiotoxicity @DISEASE_MESH:D066126 @@@cardiotoxicity@@@ that were effects were more pronounced in the untreated group. 50% vehicle controls quickly progressed into @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@heart failure@@@ (within 90 min of exposure) and did not survive the two h observation endpoint. ", "citations": {"NLM": "de Castro Brás LE, Baccanale CL, Eccleston L, Sloan T, St Antoine JC, Verzwyvelt SM, Pittman P, O'Rourke D, Meggs WJ. Efficacy of methylene blue in a murine model of amlodipine overdose. Am J Emerg Med. 2021 Jul;45():284-289. PMID: 33041135", "BibTeX": "@article{33041135, title={Efficacy of methylene blue in a murine model of amlodipine overdose.}, author={de Castro Brás LE and Baccanale CL and Eccleston L and Sloan T and St Antoine JC and Verzwyvelt SM and Pittman P and O'Rourke D and Meggs WJ}, journal={Am J Emerg Med}, volume={45}, pages={284-289}}"}}, {"_id": "34317003", "pmid": 34317003, "pmcid": "PMC8302120", "title": "A Long-Term Survivor With Alveolar Capillary Dysplasia", "journal": "JACC Case Rep", "authors": ["Yost CE", "Putnam AR", "Dishop MK", "Jorgensen LO", "Wirkus PE", "Day RW"], "date": "2020-07-29T00:00:00Z", "doi": "10.1016/j.jaccas.2020.05.055", "meta_date_publication": "2020 Aug", "meta_volume": "2", "meta_issue": "10", "meta_pages": "1492-1495", "score": 50250.188, "text_hl": "In combination with other agents, endothelin receptor antagonists and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ have been key medications in lowering pulmonary arterial pressure and managing @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@right heart failure@@@. ", "citations": {"NLM": "Yost CE, Putnam AR, Dishop MK, Jorgensen LO, Wirkus PE, Day RW. A Long-Term Survivor With Alveolar Capillary Dysplasia JACC Case Rep. 2020 Aug;2(10):1492-1495. PMID: 34317003", "BibTeX": "@article{34317003, title={A Long-Term Survivor With Alveolar Capillary Dysplasia}, author={Yost CE and Putnam AR and Dishop MK and Jorgensen LO and Wirkus PE and Day RW}, journal={JACC Case Rep}, volume={2}, number={10}, pages={1492-1495}}"}}, {"_id": "39243877", "pmid": 39243877, "title": "Prevention of Heart Failure in Hypertension - the Role of Coronary Heart Disease Events Treated with Versus without Revascularization: the ALLHAT Study.", "journal": "Am J Cardiol", "authors": ["Chen V", "Davis BR", "Kapadia SR", "Kattan MW", "Tereshchenko LG"], "date": "2024-09-05T00:00:00Z", "doi": "10.1016/j.amjcard.2024.08.033", "meta_date_publication": "2024 Sep 5", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50250.082, "text_hl": "The proportion of reference interaction indicating direct harm due to CHD event for @CHEMICAL_Lisinopril @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (234% for @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@CHF@@@; 355% for @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@HHF@@@) and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ (244% for @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@CHF@@@; 468% for @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@HHF@@@) was greater than for @CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlorthalidone@@@ (143% for @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@CHF@@@; 269% for @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@HHF@@@). ", "citations": {"NLM": "Chen V, Davis BR, Kapadia SR, Kattan MW, Tereshchenko LG. Prevention of Heart Failure in Hypertension - the Role of Coronary Heart Disease Events Treated with Versus without Revascularization: the ALLHAT Study. Am J Cardiol. 2024 Sep 5;():. PMID: 39243877", "BibTeX": "@article{39243877, title={Prevention of Heart Failure in Hypertension - the Role of Coronary Heart Disease Events Treated with Versus without Revascularization: the ALLHAT Study.}, author={Chen V and Davis BR and Kapadia SR and Kattan MW and Tereshchenko LG}, journal={Am J Cardiol}}"}}, {"_id": "39989148", "pmid": 39989148, "title": "Veno-arterial ECMO support for severe amlodipine toxicity combined with cardiogenic shock: A case report.", "journal": "Int J Artif Organs", "authors": ["Sun Y", "Wang T", "Xia J", "Hua L", "Cao S", "Zhang K"], "date": "2025-02-24T00:00:00Z", "doi": "10.1177/03913988251321620", "meta_date_publication": "2025 Feb 24", "meta_volume": "", "meta_issue": "", "meta_pages": "3913988251321620", "score": 50248.535, "text_hl": "The @SPECIES_9606 @@@patient@@@ was weaned off ECMO after 4 days and discharged home on Day 10 of hospitalization. CONCLUSION: @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@toxicity@@@ can result in severe @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@cardiac failure@@@ with @DISEASE_Shock @DISEASE_MESH:D012769 @@@circulatory collapse@@@. ", "citations": {"NLM": "Sun Y, Wang T, Xia J, Hua L, Cao S, Zhang K. Veno-arterial ECMO support for severe amlodipine toxicity combined with cardiogenic shock: A case report. Int J Artif Organs. 2025 Feb 24;():3913988251321620. PMID: 39989148", "BibTeX": "@article{39989148, title={Veno-arterial ECMO support for severe amlodipine toxicity combined with cardiogenic shock: A case report.}, author={Sun Y and Wang T and Xia J and Hua L and Cao S and Zhang K}, journal={Int J Artif Organs}, pages={3913988251321620}}"}}, {"_id": "37075940", "pmid": 37075940, "title": "The First Dedicated Comprehensive Heart Failure Program in the United States: The Division of Circulatory Physiology at Columbia Presbyterian (1992-2004).", "journal": "J Card Fail", "authors": ["Packer M"], "date": "2023-04-17T00:00:00Z", "doi": "10.1016/j.cardfail.2023.03.028", "meta_date_publication": "2023 Apr 17", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50240.22, "text_hl": "The major research achievements of the division included (1) the development of beta-blockers for @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@heart failure@@@, from initial hemodynamic assessments to proof-of-concept studies to large-scale international trials; (2) the development and definitive assessment of @CHEMICAL_flosequinan @CHEMICAL_MESH:C047316 @@@flosequinan@@@, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, and endothelin antagonists; (3) initial clinical trials and concerns with nesiritide; (4) large-scale trials evaluating dosing of angiotensin converting-enzyme inhibitors and the efficacy and safety of @GENE_MME @GENE_4311 @@@neprilysin@@@ inhibition; (5) identification of key mechanisms in @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@heart failure@@@, including neurohormonal activation, microcirculatory endothelial dysfunction, deficiencies in peripheral vasodilator pathways, noncardiac factors in driving @DISEASE_Dyspnea @DISEASE_MESH:D004417 @@@dyspnea@@@, and the first identification of subphenotypes of @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@heart failure@@@ and a preserved ejection fraction; (6) the development of a volumetric approach to the assessment of myocardial shortening; (7) conceptualization and early studies of cardiac contractility modulation as a treatment for @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@heart failure@@@; (8) novel approaches to the identification of cardiac allograft rejection and new therapeutics to prevent @DISEASE_Bronchiolitis_Obliterans_Syndrome @DISEASE_MESH:D000092122 @@@allograft vasculopathy@@@; and (9) demonstration of the effect of left ventricular assist devices to induce reverse remodeling, and the first randomized trial showing a survival benefit with ventricular assist devices. ", "citations": {"NLM": "Packer M. The First Dedicated Comprehensive Heart Failure Program in the United States: The Division of Circulatory Physiology at Columbia Presbyterian (1992-2004). J Card Fail. 2023 Apr 17;():. PMID: 37075940", "BibTeX": "@article{37075940, title={The First Dedicated Comprehensive Heart Failure Program in the United States: The Division of Circulatory Physiology at Columbia Presbyterian (1992-2004).}, author={Packer M}, journal={J Card Fail}}"}}]}